Roche Diagnostics Corporation
Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. Through prime federal contract awards, Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to the Department of Veterans Affairs, Department of Defense, Department of Health and Human Services, Department of Agriculture, Department of Commerce, and other federal agencies. Many awards have been made through Roche's multiple General Services Administration (GSA) Schedule contracts for products categorized under laboratory instruments, equipment, and supplies. Roche has also received subcontract awards to provide medical and surgical equipment or supplies in support of prime contractors like Cardinal Health.
Roche Diagnostics has been awarded contracts to supply clinical chemistry analyzers, reagents, and testing services to provide immunochemistry, hematology, molecular diagnostics, microbiology, histology, and other laboratory capabilities at VA hospitals, military treatment facilities, NIH research centers, and Indian Health Service locations across the country. Awards have provided viral testing systems, pathology staining equipment, blood glucose monitors, coagulation test strips, and similar medical devices and consumables without set-aside designations. Roche has performed as a prime contractor as well as a subcontractor on contracts funding healthcare services for veterans, active duty military personnel, dependents, retirees, and civilian patients.
Roche Diagnostics holds several Indefinite Delivery Contracts and Blanket Purchase Agreements which establish long-term vehicles for federal customers to acquire laboratory instruments, reagents, test kits, and associated products and services on an as-needed basis. For example, Roche was awarded a 5-year BPA by the VA to provide chemistry and immunochemistry laboratory testing worth over $7 million. A $5.9 million delivery order was also placed against Roche's $30 million IDC for chemistry analyzers and supplies to support VA hospitals in California. Another IDC with the Defense Health Agency provides Roche with ongoing authority to supply chemistry reagents to military treatment facilities across a 5-year ordering period valued at approximately $5.3 million total. These and other IDVs held by Roche streamline federal agencies’ ability to purchase essential medical equipment and consumables through established pricing and terms with the vendor.
JDMDFEZBYH36 325413
Not listed 9115 Hague Rd, Indianapolis, IN 46256, USA
1/15/02 3/29/25 U.s. Arkray, Inc.
U.s. Arkray, Inc. is a foreign-owned, for-profit manufacturer of medical products that are simple, convenient, and easy to use. The company is registered under the Laboratory Division Division and manufactures cost effective diabetes care products and clinical chemistry equipment.
U.S. Arkray, Inc. has been awarded numerous firm fixed price blanket purchase agreement call contracts by the Department of Veterans Affairs Veterans Health Administration and the Defense Health Agency. These contracts primarily provide A1C hematology control and proficiency testing reference materials to support laboratory quality assurance programs at VA medical centers and military hospitals. The reference materials enable testing of hematology analyzers to maintain quality control and accuracy of diagnostic tests performed on veterans and service members. Contract values range from around $4,000 to $60,000 for one year periods of performance. U.S. Arkray holds a position on the General Services Administration's Multiple Award Schedule 66-III for Critical Analyzers, Laboratory against which these call orders are placed. No set-asides were used for the awarded contracts.
U.S. Arkray, Inc. holds two major federal contract IDVs. The first is a Multiple Award Federal Supply Schedule contract against GSA Schedule 66-III with a potential value of $5.8 million awarded by the VA VHA VISN 12. This contract provides laboratory testing analyzers and related supplies on a cost-per-test basis for VA medical centers from 2022 to 2026. The second IDV is a blanket purchase agreement valued at up to $1,047,982.50 also awarded by VA VHA Networks 10 and 12 against GSA Schedule 66-III. This BPA runs through September 2024 and calls for the delivery of A1C hematology control and reference materials to VA facilities to maintain quality assurance of hematology testing for veterans. Both IDVs utilize U.S. Arkray's position as an approved vendor under the GSA Schedules program for laboratory equipment and allow the VA to procure diagnostic testing products and services to support its integrated healthcare mission.
CNJFB9YAV8D7 339112
Not listed 5190 W 76th St, Edina, MN 55439, USA
4/4/13 4/26/25 Becton, Dickinson And Company
Becton, Dickinson and Company is a leading global medical technology company that provides a range of medical supplies, devices, laboratory equipment, and diagnostic products. Through its IDS division, operating as BD Diagnostic Systems, the company serves as a manufacturer of medical and laboratory products supplied to federal government customers.
Becton, Dickinson has received over $500 million in prime federal contract awards to provide critical medical equipment, supplies, and testing services to various agencies. As a prime contractor, BD Diagnostic Systems has furnished blood culture systems, microbiology analyzers, reagents, and other clinical laboratory products to Department of Veterans Affairs hospitals and healthcare networks valued at over $300 million. They have also provided COVID-19 and infectious disease testing services to VA medical centers under various Blanket Purchase Agreements. Additionally, BD receives contracts from the Department of Health and Human Services, the Department of Defense, and other agencies to supply diagnostic equipment, laboratory instruments, test kits, and related products to support healthcare services and biomedical research programs. Awards have included $49 million in indefinite delivery vehicles from the Defense Logistics Agency for laboratory supplies and $40 million from the HHS Office of the Assistant Secretary for Preparedness and Response to develop respiratory disease testing platforms. Becton, Dickinson has also served as a subcontractor providing medical and surgical equipment and supplies under prime contractors such as Cardinal Health.
Becton, Dickinson holds several Indefinite Delivery Vehicles and Blanket Purchase Agreements which provide streamlined ordering of goods and services to federal customers. As a designated supplier under the GSA Schedule program, BD Diagnostic Systems maintains a Critical Analyzers, Laboratory schedule contract allowing customers to directly place task orders against pre-negotiated terms for scientific equipment and clinical diagnostic services. The company also holds a 5-year IDIQ contract from the VA to provide cytopathology equipment and supplies, enabling the continuous purchase of specialized reagents, workstations, and testing through the delivery order process. Additionally, Becton, Dickinson was awarded a $49 million IDIQ to supply laboratory reagents and consumables to Defense Department facilities over a 5-year base period. The agreement contains provisions to ensure compliance with domestic preference laws and trade agreements.
DP4CNEMUF5F3 334516
Not listed 7 Loveton Cir, Sparks Glencoe, MD 21152, USA
9/26/01 8/21/25 Siemens Healthcare Diagnostics Inc.
Siemens Healthcare Diagnostics Inc., doing business as the Siemens Healthcare Diagnostics Division, is a subsidiary of Siemens Aktiengesellschaft, a global technology leader in industry, infrastructure, transport, and healthcare. It provides in vitro diagnostic solutions and laboratory services to various federal agencies.
Through prime federal contract awards, Siemens Healthcare Diagnostics Inc. primarily supplies diagnostic equipment, reagents, consumables, and associated services to support clinical laboratory testing operations at government medical facilities. Its product offerings encompass chemistry, hematology, immunoassay, coagulation, and point-of-care analyzers along with necessary reagents, calibrators, and controls. Federal customers include the Department of Veterans Affairs, Department of Defense agencies like the Defense Health Agency and Army Bureau of Medicine, Department of the Air Force, Department of the Navy Bureau of Medicine and Surgery, Indian Health Service, and Department of Justice Bureau of Prisons. The company holds multiple Indefinite Delivery Contracts, Blanket Purchase Agreements, and delivery orders against its GSA Schedule for Critical Analyzers, Laboratory. Awards are typically firm fixed price, with no set-asides used.
Siemens Healthcare Diagnostics Inc. does not appear to have any prime federal grant awards based on the provided information. However, it was listed as a sub-recipient on a National Institutes of Health grant to the University of Utah for a multi-center study validating magnetic resonance imaging analysis of carotid atherosclerotic disease.
Siemens Healthcare Diagnostics Inc. holds several active Indefinite Delivery Vehicles (IDVs) awarded by federal agencies to procure diagnostic equipment and services. These include single and multiple award Blanket Purchase Agreements with the Department of Veterans Affairs, Defense Health Agency, Department of the Air Force, and Department of the Navy Bureau of Medicine and Surgery to provide laboratory analyzers, reagents, consumables, and maintenance support. A notable IDV is a $4.5 million single award indefinite delivery contract with the Navy Bureau of Medicine and Surgery to supply fentanyl reagent test kits. Siemens has received over $500,000 in task orders against this vehicle to date. The company also has an IDV with the Department of Veterans Affairs for immunology cost per test services valued at over $1 million. These IDVs enable federal medical treatment facilities to efficiently order testing products and diagnostic support services from Siemens Healthcare Diagnostics to sustain critical laboratory operations.
GC14SNHB3JN1 334516
Not listed 511 Benedict Ave, Tarrytown, NY 10591, USA
4/2/98 10/4/25 Polymedco LLC
Polymedco LLC is a for-profit organization that does business as Polymedco Cancer Diagnostic Products. It provides critical analyzers, laboratory equipment, and various cancer diagnostic products to federal agencies, primarily the Department of Veterans Affairs (VA). Polymedco specializes in supplying automated fecal immunochemical occult blood analyzers, fecal immunochemical tests, colorectal analyzers, and associated supplies, reagents, and services.
Through prime federal contract awards, Polymedco has supplied the VA with a wide range of goods and services to support the agency's cancer screening, diagnosis, and treatment initiatives across multiple Veterans Integrated Service Networks (VISNs). Notable contracts include Blanket Purchase Agreements (BPAs) and indefinite delivery vehicles for fecal immunochemical tests, immunochemical fecal occult blood testing, fit testing services, analyzers, collection devices, reagents, and other consumables. The majority of these contracts have been awarded by various VISNs within the VA's Veterans Health Administration, with performance primarily taking place at Polymedco's facility in Cortlandt Manor, New York. The contracts are typically firm-fixed-price arrangements and do not have set-aside designations, reflecting full and open competition. Many of these awards leverage Polymedco's position on the General Services Administration's Federal Supply Schedule for Critical Analyzers, Laboratory.
Polymedco LLC holds multiple federal contract Indefinite Delivery Vehicles (IDVs), primarily Blanket Purchase Agreements (BPAs), to provide a range of cancer screening, diagnostic, and treatment-related goods and services to the VA. These IDVs, awarded by various VISNs under the VA Veterans Health Administration, enable the efficient procurement of fecal immunochemical tests, colorectal analyzers, immunochemical fecal occult blood testing services, fit testing instruments, and associated supplies and reagents. The IDVs fall under Polymedco's parent General Services Administration Federal Supply Schedule contract for Critical Analyzers, Laboratory. Through these vehicles, Polymedco has received task orders and BPA calls valued from a few thousand dollars to over $1.4 million to deliver the requested products and services to VA medical facilities nationwide. The IDVs aim to establish standardized, multi-year contract vehicles for the VA to acquire required cancer screening equipment, testing supplies, and diagnostic services from Polymedco without repeated competition.
STNDUK44ENE8 325413
Not listed 510 Furnace Dock Rd, Cortlandt, NY 10567, USA
9/6/01 4/10/25